Bellerophon Therapeutics Pink Sheet Forecast - Simple Exponential Smoothing
BLPHDelisted Stock | USD 0.07 0.04 35.00% |
The Simple Exponential Smoothing forecasted value of Bellerophon Therapeutics on the next trading day is expected to be 0.07 with a mean absolute deviation of 0.02 and the sum of the absolute errors of 1.23. Bellerophon Pink Sheet Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Bellerophon Therapeutics stock prices and determine the direction of Bellerophon Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Bellerophon Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. Bellerophon |
Most investors in Bellerophon Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Bellerophon Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Bellerophon Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Bellerophon Therapeutics simple exponential smoothing forecast is a very popular model used to produce a smoothed price series. Whereas in simple Moving Average models the past observations for Bellerophon Therapeutics are weighted equally, Exponential Smoothing assigns exponentially decreasing weights as Bellerophon Therapeutics prices get older. Bellerophon Therapeutics Simple Exponential Smoothing Price Forecast For the 25th of April
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Bellerophon Therapeutics on the next trading day is expected to be 0.07 with a mean absolute deviation of 0.02, mean absolute percentage error of 0, and the sum of the absolute errors of 1.23.Please note that although there have been many attempts to predict Bellerophon Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Bellerophon Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Bellerophon Therapeutics Pink Sheet Forecast Pattern
Backtest Bellerophon Therapeutics | Bellerophon Therapeutics Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Bellerophon Therapeutics pink sheet data series using in forecasting. Note that when a statistical model is used to represent Bellerophon Therapeutics pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.AIC | Akaike Information Criteria | 110.2992 |
Bias | Arithmetic mean of the errors | 0.0108 |
MAD | Mean absolute deviation | 0.0204 |
MAPE | Mean absolute percentage error | 0.0925 |
SAE | Sum of the absolute errors | 1.225 |
Predictive Modules for Bellerophon Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bellerophon Therapeutics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bellerophon Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bellerophon Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bellerophon Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of Bellerophon Therapeutics could also be used in its relative valuation, which is a method of valuing Bellerophon Therapeutics by comparing valuation metrics with similar companies.
Risk & Return | Correlation |
Bellerophon Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Bellerophon Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bellerophon Therapeutics shares will generate the highest return on investment. By undertsting and applying Bellerophon Therapeutics pink sheet market strength indicators, traders can identify Bellerophon Therapeutics entry and exit signals to maximize returns.
Accumulation Distribution | 0.5 | |||
Daily Balance Of Power | (0.71) | |||
Rate Of Daily Change | 0.65 | |||
Day Median Price | 0.0753 | |||
Day Typical Price | 0.0718 | |||
Market Facilitation Index | 0.0495 | |||
Price Action Indicator | (0.03) | |||
Period Momentum Indicator | (0.04) |
Bellerophon Therapeutics Risk Indicators
The analysis of Bellerophon Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Bellerophon Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bellerophon pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 5.05 | |||
Standard Deviation | 11.29 | |||
Variance | 127.43 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Bellerophon Pink Sheet
If you are still planning to invest in Bellerophon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bellerophon Therapeutics' history and understand the potential risks before investing.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Global Correlations Find global opportunities by holding instruments from different markets |